These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3300230)

  • 21. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the antiarrhythmic effects of Sotalol given orally].
    Fauchier JP; Neel C; Garabedian V; Cosnay P; Brochier M
    Ann Cardiol Angeiol (Paris); 1982 Jun; 31(4):329-38. PubMed ID: 7137863
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rational treatment of heart rhythm disorders. International symposium on "The Management of Cardiac Arrhythmias: the Role of Encainide and Sotalol". 24-25 March 1988, Wallingford (USA)].
    Fortschr Med Suppl; 1988; 43():1-22. PubMed ID: 2898424
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacologic management of arrhythmias.
    Bink-Boelkens MT
    Pediatr Cardiol; 2000; 21(6):508-15. PubMed ID: 11050274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: particular reference to sotalol.
    Singh BN
    Am J Cardiol; 1990 Jan; 65(2):3A-11A; discussion 35A-36A. PubMed ID: 2403733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sotalol in treatment of pediatric severe (refractory) cardiac arrhythmias].
    Guo BJ; Li XM; Lu P; Qin DG; Wang L
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):780-1. PubMed ID: 14731366
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(2):37A-42A; discussion 51A-52A. PubMed ID: 2403734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sotalol--pharmacology, effect on hemodynamics and interactions].
    Nyznyk M; Walczak F; Jodkowska-Skarzyńska M; Kulicka D
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):321-3. PubMed ID: 8415246
    [No Abstract]   [Full Text] [Related]  

  • 30. Sotalol: a unique class III antiarrhythmic agent.
    Barlow JB; Obel IW; Pocock WA; McKibbin JK
    Am J Cardiol; 1994 May; 73(12):932-3. PubMed ID: 8018196
    [No Abstract]   [Full Text] [Related]  

  • 31. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.
    Hohnloser SH; Zabel M; Krause T; Just H
    Am Heart J; 1992 May; 123(5):1220-4. PubMed ID: 1575137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration/response relations for the multiple antiarrhythmic actions of sotalol.
    Woosley RL; Barbey JT; Wang T; Funck-Brentano C
    Am J Cardiol; 1990 Jan; 65(2):22A-27A; discussion 35A-36A. PubMed ID: 2294688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding clinical role of unique class III antiarrhythmic effects of sotalol.
    Singh BN
    Am J Cardiol; 1990 Jan; 65(2):84A-88A. PubMed ID: 2403738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ESVEM tells us what we don't know.
    Anderson KP; Schloss EJ
    Circulation; 1995 Nov; 92(10):3144. PubMed ID: 7586288
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of sotalol for life-threatening ventricular arrhythmias.
    Roden DM
    Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New antiarrhythmic drug in pediatric use: sotalol.
    Pfammatter JP; Paul T
    Pediatr Cardiol; 1997; 18(1):28-34. PubMed ID: 8960489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.